乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Primary Care >

RSV

News, opinions and meeting coverage in primary care.

A computer rendering of the cutaway of a respiratory syncytial virus

<乌鸦传媒>Cardiac Events Common in Older, Hospitalized RSV Patients

New RSV vaccines could reduce risk, researchers said

A computer rendering of a respiratory syncytial virus

<乌鸦传媒>CDC Monitoring Rare Neurologic Events After RSV Vaccination

Cases of Guillain-Barre syndrome in vaccinated older adults slightly higher than background rates

A computer rendering of RSV viruses in the lungs.

<乌鸦传媒>Moderna's mRNA RSV Vaccine Effective in Older Adults

Whether it provides lasting protection remains to be seen

IDWeek over a photo of Boston Convention & Exhibition Center - Boston, MA.

<乌鸦传媒>RSV Vaccine Maintains Efficacy Across Two Seasons in Seniors

And second dose after 1 year appeared to add no extra protection

A photo of a senior man and woman in wheelchairs in a nursing home hallway.

<乌鸦传媒>Severity of RSV Hospitalizations Rivals COVID in Older Adults

Consider age, underlying medical conditions in RSV vaccine recs, researchers say

A photo of a male physician holding three vials of differently colored liquids and a syringe.

<乌鸦传媒>Can COVID, Flu, and RSV Shots Be Given at the Same Time?

Here's how experts are strategizing fall vaccines

A computer rendering of respiratory syncytial virus particles.

<乌鸦传媒>What to Know About New Tools to Fight RSV

Two vaccines and a monoclonal antibody aim to bring down the burden of RSV

FDA APPROVED Unadjuvanted, bivalent RSV prefusion F protein vaccine (Abrysvo) over a computer rendering of RSV viruses.

<乌鸦传媒>Second RSV Vaccine Lands Approval for Older Adults

Abrysvo approved for adults 60 and up

FDA VRBPAC RSVPreF3 vaccine (AREXVY) over a computer rendering of a cutaway RSV virus.

<乌鸦传媒>Second RSV Vaccine for Older Adults Gets Thumbs Up From FDA Advisors

VRBPAC unanimously endorses efficacy of GSK's protein fusion vaccine, not quite as sold on safety

FDA VRBPAC RSV prefusion F protein vaccine (ABRYSVO) over a computer rendered cutaway of the RSV virus.

<乌鸦传媒>FDA Panel Backs Pfizer's RSV Vaccine for Older Adults

But panelists raise multiple concerns over phase III trial data

A computer rendered cutaway view of the respiratory syncytial virus

<乌鸦传媒>FDA Flags Potential Guillain-Barre Risk With RSV Vaccine Candidates

Both vaccines demonstrated high efficacy against symptomatic illness in large phase III trials

A computer rendering of respiratory syncytial viruses

<乌鸦传媒>RSV Vaccine Succeeds in Phase III Trial of Older Adults

Here's what it could mean in practice

IDWeek over a photo of the Walter E. Washington Convention Center in Washington, DC

<乌鸦传媒>Vaccine Candidates for RSV Ward Off Severe Illness in Older Adults

Trials show upwards of 85% protection against more severe cases of respiratory syncytial virus

A scanning electron micrograph of human respiratory syncytial virus

<乌鸦传媒>Novel Drug Shows Promise for Respiratory Syncytial Virus

Challenge trial involving healthy adults showed superiority to placebo at multiple doses

2021 YEAR IN REVIEW respiratory syncytial virus over a computer rendering of the virus.

<乌鸦传媒>Year in Review: Respiratory Syncytial Virus

Vaccine development for older adults continued apace, virus roared back in kids

IDWeek over a computer rendering of the COVID-19 virus.

<乌鸦传媒>Vaccine Could Be Shot in the Arm Against RSV in Older Adults

CYPRESS proof-of-concept study shows high efficacy against acute illness